Biotech Research

Found 577 articles

• Diabetic Nephropathy - A Drug Pipeline Analysis Report by Technavio

  9/21/2018

  Technavio has announced their latest drug pipeline analysis report on diabetic nephropathy. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of diabetic nephropathy.

• Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders

  9/20/2018

  License with Nationwide Children’s Hospital (NCH) through the Acquisition of Celenex (NCH Spinout)

• Companies join forces to showcase how AI algorithms can progressively be adopted in study conduct, at DPharm 2018

  9/20/2018

  Pioneering partners Cmed and Innovative Physics have combined forces to showcase The Real Time Medical Imaging Users Tool Kit®, which uses artificial intelligence to support secure, rapid diagnostics in clinical trials, at DPharm 2018.

• GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies"

  9/20/2018

  Nationally recognized researchers from the Medical Cannabis World will discuss the benefits of medical cannabis

• LA BioMed At Center of LA County Bioscience Summit 

  9/20/2018

  Dr. Meyer to lead panel of thought leaders capitalizing on region’s role as influential bioscience hub

• ApoCell Announces Publication of First Therapeutic Target Biomarker Correlation in Circulating Tumor Cells and Overall Survival in Patients with Solid Tumors

  9/19/2018

  ApoCell, Inc. announced today the publication of biomarker results from the BEACON Phase 3 clinical trial that utilized Apocell's proprietary circulating tumor cell enrichment system, ApoStream®.

• Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

  9/19/2018

  The Institute of Human Virology at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD).

• SCRS Announces Finalists for the Global Site Patient Recruitment Innovation Award (SPRIA)

  9/19/2018

  Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Patient Recruitment Innovation Award (SPRIA). Sponsor by Acurian, the SPRIA recognizes and honors highly successful innovative patient enrollment initiatives executed by sites.

• Celebrating 10 Years of Sekisui XenoTech

  9/19/2018

  American Innovation Meets Japanese Vision with a Global Outlook

• Children’s Hospital Los Angeles Team Identifies Developmental Stage for No. 1 Eye Tumor in Children

  9/18/2018

  Investigators at Children's Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The finding could open the door for future interventions in retinoblastoma (RB), a tumor of the retina that affects children under five years of age.

• New grant funds pilot study of female fertility decision tool for cancer survivors

  9/18/2018

  Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a five-year, $693,000 grant from the National Institutes of Health (NIH) to develop and test a digital health platform to help young female cancer survivors evaluate their options for having children, make decisions and plan for the future.

• Biocom Applauds Introduction of Rare Disease Fund Act

  9/18/2018

  Biocom, the association representing the life science industry of California, today applauded the introduction of H.R. 6801, the Rare Disease (RaD) Fund Act by U.S. Representatives Juan Vargas (D-CA), Scott Peters (D-CA) and Tom Rooney (R-FL).

• GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion; Cannabis Is Medicine; at the State of Cannabis Conference on the Queen Mary

  9/18/2018

  GB Sciences, Inc. (OTCQB: GBLX) announces that Dr. Andrea Small-Howard will be moderating the panel discussion which kicks-off the "Cannabis Is Medicine Track" and explores important Research Initiatives.

• Immune-Onc Therapeutics Announces Key Executive Appointments and Series B Funding

  9/18/2018

  Immune-Onc Therapeutics (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, today announced the appointments of Dr. Adrian Jubb as Chief Medical Officer and of Dr. An Song as Senior Vice President of Development Sciences.

• Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

  9/18/2018

  Cytisine Demonstrated Superior Abstinence Rates Compared to Nicotine Replacement Therapy

• Hyundai Hope On Wheels Presents Children's Hospital Colorado With Hyundai Hope Scholar And Young Investigator Grant Totaling $500,000 To Support Pediatric Cancer Research

  9/17/2018

  In the newest rounds of grants marking its 20th anniversary, Hyundai Hope On Wheels® 501(c)(3) celebrates National Childhood Cancer Awareness Month by awarding grants totaling $500,000 to Dr. Michael Verneris and Masanori Hayashi of Children's Hospital Colorado.

• Artificial Intelligence Tool Accurately Identifies Cancer Type and Genetic Changes in Each Patient's Lung Tumor

  9/17/2018

  A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

• Biocom Opens San Francisco Bay Area Office and Forms Bay Area Advisory Board

  9/17/2018

  Biocom, the association representing the California life science industry, today announced the formation of a San Francisco Bay Area advisory board, as well as the grand opening of its Bay Area office.

• Global Lyme Alliance's 4th Annual New York City Gala Bringing Together Celebrities, Business Leaders, and Top Scientists

  9/17/2018

  Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness, will hold its 4th annual New York City Gala on October 11th at Cipriani 42nd Street.

• Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership Team

  9/17/2018

  Dr Edward Stevens appointed as Head of Drug Discovery, and Dr Andrew Lightfoot as Head of Medicinal Chemistry and Discovery Funding